Abbott's next generation Xience Xpedition drug eluting stent receive CE Mark ... pharmabiz.com Abbott's Xience Xpedition Everolimus Eluting Coronary Stent System received CE Mark in Europe for the treatment of coronary artery disease. The company is launching the product immediately in CE Mark countries. Xience Xpedition features a new stent ... Abbott Reveals CE Mark Approval For XIENCE Xpedition Everolimus Eluting ... Abbott Announces CE Mark and European Launch of Next-Generation XIENCE ... Updated Xience nets CE Mark, with shorter DAPT time |
